Dr. Richard Kim, MD
Claim this profileMoffitt Cancer Center
Studies Pancreatic Cancer
Studies Colorectal Cancer
14 reported clinical trials
28 drugs studied
Area of expertise
1Pancreatic Cancer
Stage III
Stage IV
2Colorectal Cancer
Stage IV
Affiliated Hospitals
Moffitt Cancer Center
University Of Alabama At Birmingham
Clinical Trials Richard Kim, MD is currently running
LSTA1 + Standard Care
for Advanced Cancers
This trial is testing a new drug called LSTA1 combined with standard treatment in patients with advanced cholangiocarcinoma. It aims to find out if this combination is safer and more effective than the standard treatment alone.
Recruiting0 awards Phase 2
Nutrition Support Program
for Pancreatic Cancer
The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are receiving chemotherapy.
Recruiting1 award N/A5 criteria
More about Richard Kim, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Richard Kim, MD has experience with
- Pembrolizumab
- Regorafenib
- Sym021
- Sym022
- Sym023
- Irinotecan Hydrochloride
Breakdown of trials Richard Kim, MD has run
Pancreatic Cancer
Colorectal Cancer
Liver Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Kim, MD specialize in?
Richard Kim, MD focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Richard Kim, MD currently recruiting for clinical trials?
Yes, Richard Kim, MD is currently recruiting for 6 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Richard Kim, MD has studied deeply?
Yes, Richard Kim, MD has studied treatments such as Pembrolizumab, Regorafenib, Sym021.
What is the best way to schedule an appointment with Richard Kim, MD?
Apply for one of the trials that Richard Kim, MD is conducting.
What is the office address of Richard Kim, MD?
The office of Richard Kim, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.